In a year of many global market challenges that have impacted the automotive industry, the MEMA Original Equipment Suppliers Annual Conference held ...
As President-elect Donald Trump nears his return to the White House, the U.S. Navy’s nuclear-armed sea-launched cruise ...
NEW YORK-- ( BUSINESS WIRE )--Hess Corporation (NYSE: HES) announced today that John Hess, Chief Executive Officer, will ...
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...
Best Genomics Stocks To Buy Right Now. Genomics is the study of genes and how they function. Many rapidly growing companies ...
The U.S. Air Force Research Laboratory has chosen California's Yates Electrospace Corp. to build six CLS-200 autonomous, ...
On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $88.4 which represents a decrease of $-3.71 or -4.03% from the prior close of $92.11. The stock opened at $91.71 and ...
Fintel on MSN8d
Wolfe Research Initiates Coverage of BioMarin Pharmaceutical (BMRN) with Outperform RecommendationFintel reports that on November 15, 2024, Wolfe Research initiated coverage of BioMarin Pharmaceutical (NasdaqGS:BMRN) with a ...
Fintel on MSN9d
Wolfe Research Initiates Coverage of Eli Lilly and (LLY) with Outperform RecommendationFintel reports that on November 15, 2024, Wolfe Research initiated coverage of Eli Lilly and (NYSE:LLY) with a Outperform ...
Wolfe projects a positive outlook for Pharma & Large-Cap Biotech stocks despite potential policy changes as part of Make America Healthy Again movement. Read more here.
Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target Published first on TheFly – the ...
Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson with an Outperform rating and $190 price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback